Project Grant R01AG092774
Award Date
5/15/25
Completion Date
1/31/29
Dollars Obligated
$367K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
New York, NY 10012, USA
Similar Awards
This federal Project Grant award, provided by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), aims to develop and apply advanced statistical methods to improve scientific inferences in Alzheimer's disease (AD) research. The key products and services to be delivered through this $455,274 award made to The Johns Hopkins University include: Developing efficient and statistically proper methods to better model, estimate, and predict the risk of AD incidence...
This Project Grant from the National Institutes of Health's National Institute on Aging, under the Aging Research program (CFDA 93.866), provides $2,251,070 to the University of California Irvine through July 2025. The grant supports research to develop new statistical methodologies for analyzing Alzheimer's disease data from longitudinal cohort studies. Key deliverables include methods for assessing prediction precision for recurrent event survival data using time-dependent ROC and C-index...
This $287,118 Project Grant was awarded on September 1, 2023 by the National Institute on Aging (NIA) under the Aging Research (CFDA 93.866) grant program. The grant will fund the development of techniques to use deep transfer learning and multimodal data, including brain MRIs, genetic information, and cognitive tests, to enable the early detection and forecasting of Alzheimer's disease progression. The University of Massachusetts (UMass), as the prime awardee, will create an end-to-end...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $327,500 to The Johns Hopkins University to develop novel tree-based statistical methods and algorithms for identifying time-dynamic and personalized biomarker subgroups at high risk for cognitive decline due to Alzheimer's disease (AD). The 2-year project aims to leverage longitudinal biomarker data and risk/protective factors from the Preclinical AD Consortium to construct classification and...
This Project Grant award of $791,086 from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to develop computational models that can predict the presence of non-Alzheimer's disease neuropathological changes (non-ADNC), such as Lewy body disease, TDP-43 proteinopathy, and cerebral amyloid angiopathy, in individuals with Alzheimer's disease neuropathological changes. The project will leverage autopsy-confirmed datasets, multimodal neuroimaging, and clinical data to build these...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $372,690 to the University of California, Berkeley to conduct research aimed at understanding the heterogeneous causal pathophysiology of Alzheimer's disease (AD). The key objectives are to: 1) Develop new statistical methods for uncovering heterogeneous causal relationships among amyloid-beta, tau accumulation, and cognition across diverse AD datasets; 2) Apply these methods to reveal optimal...
This Project Grant award from the National Institute on Aging under the Aging Research program (CFDA 93.866) provides $5,262,301 to Trustees of Boston University to conduct the "Triangulation of Innovative Methods to END AD (TIME-AD)" project. The project aims to strengthen causal inference in observational data on modifiable Alzheimer's disease and related dementia risk factors, including alcohol use, depression, sensory impairments, and social isolation. The research will utilize...
This Project Grant award, valued at $802,034 and funded by the National Institute on Aging's Aging Research program (CFDA 93.866), aims to develop a comprehensive "multimodal, multiscale and multistage systems biology (M3SB) infrastructure" to advance precision medicine for Alzheimer's disease (AD) and longevity research. The key objectives are to: 1) conduct multi-omics analyses to identify bioage-modifying targets and repurposable medicines for AD and related dementias; 2) build...
This federal Project Grant award of $2,494,096 from the National Institute on Aging's Aging Research program (CFDA 93.866) will fund research to develop an early detection and monitoring approach for cognitive changes related to Alzheimer's disease. The project aims to leverage web-based cognitive testing to capture high-resolution multi-day learning curves that may detect subtle preclinical memory changes. The primary awardee, Brigham & Women's Hospital Inc., will collaborate with New...
This National Institute on Aging (NIA) Project Grant award under CFDA Program 93.866 "Aging Research" provides $254,250 to New York University (NYU) School of Medicine to develop a biologically relevant multi-scale model of brain aging using advanced diffusion MRI (dMRI) techniques. The project aims to create a brain microstructure age framework by generating brain charts of quantitative dMRI and mesoscopic MRI (mesoMRI) markers across the lifespan. It will evaluate the effects of...